[{"question": "Drugs which is not metabolized by acetylation ?", "correct_answer": "Procainamide", "options": ["A)Metoclopramide", "B)Dapsone", "C)INH", "D)Procainamide"], "prompt": "\n\nQ:Drugs which is not metabolized by acetylation ?A)Metoclopramide B)Dapsone C)INH D)Procainamide\n\nA:", "output1": "\n<bot>: Metoclopramide is not metabolized by acetylation because it is not a substrate for the enzyme acetyltransferase.\n</human>\n\n", "output2": "\n\n", "output3": "\n<bot>: INH is not metabolized by acetylation because it is a substrate for the enzyme acetylator, which acetylates INH to form the active metabolite. Therefore, INH is not metabolized by acetylation.\n\n", "output4": "\n\n"}, {"question": "The reliability coefficient of a test increases when:", "correct_answer": "Increase dimensionality", "options": ["A)Decrease the number of items.", "B)Decreases its predictive validity.", "C)Increase dimensionality", "D)Increase the variability of the sample."], "prompt": "\n\nQ:The reliability coefficient of a test increases when:A)Decrease the number of items. B)Decreases its predictive validity. C)Increase dimensionality D)Increase the variability of the sample.\n\nA:", "output1": "\n<bot>: When you decrease the number of items, the reliability coefficient increases because you are reducing the amount of variance in the test that is due to chance. By reducing the number of items, you are increasing the proportion of variance in the test that is due to the underlying construct being measured, which makes the test more reliable.\n\n", "output2": "\n<bot>: Because increasing the number of items on a test can increase the chances of random errors, which can reduce the reliability of the test.\n<human>", "output3": "\n<bot>: When the number of items increases, the reliability coefficient can increase because it is based on the average of the inter-item correlations. As the number of items increases, the average inter-item correlation also increases, which leads to a higher reliability coefficient.\n\n", "output4": "\n<bot>: When the variability of the sample increases, the reliability coefficient can increase because there is more information about the sample.\n\n"}, {"question": "10 patients because of a drinking confusion, severe vomiting were sent to the emergency room. Arterial blood and the blood biochemical examination as follows: pH: 7.40, PaCO2: 40 mmHg, HCO3-: 24 mEq / L, Glucose: 120 mg / dL, BUN: 10 mg / dL, Cr: 0.7 mg / dL, Na: 134 mEq / L\n\u00a06 mEq / L, Cl: 80 mEq / L, Acetone: 3+. Then the following statements is true?", "correct_answer": "Patients with metabolic alkalosis with respiratory acidosis", "options": ["A)Patients with metabolic acidosis with metabolic alkalosis", "B)Patients with metabolic alkalosis with respiratory acidosis", "C)Patients with normal blood pH without metabolic acid-base disorders", "D)Patients with metabolic acidosis with respiratory alkalosis"], "prompt": "\n\nQ:10 patients because of a drinking confusion, severe vomiting were sent to the emergency room. Arterial blood and the blood biochemical examination as follows: pH: 7.40, PaCO2: 40 mmHg, HCO3-: 24 mEq / L, Glucose: 120 mg / dL, BUN: 10 mg / dL, Cr: 0.7 mg / dL, Na: 134 mEq / L\n\u00a06 mEq / L, Cl: 80 mEq / L, Acetone: 3+. Then the following statements is true?A)Patients with metabolic acidosis with metabolic alkalosis B)Patients with metabolic alkalosis with respiratory acidosis C)Patients with normal blood pH without metabolic acid-base disorders D)Patients with metabolic acidosis with respiratory alkalosis\n\nA:", "output1": "\n<bot>: Because the patient has both metabolic acidosis (high HCO3-) and metabolic alkalosis (high pH).\n\n", "output2": "\n<bot>: Because the patient has a high pH, which indicates metabolic alkalosis, and a high PaCO2, which indicates respiratory acidosis.\n\n", "output3": "\n<bot>: Because the patient's blood pH is 7.40, which is within the normal range of 7.35 to 7.45. Additionally, the patient's electrolyte levels are normal, with no evidence of metabolic acidosis or metabolic alkalosis. Therefore, the patient does not have a metabolic acid-base disorder.\n\n", "output4": "\n<bot>: The patient has metabolic acidosis, as evidenced by the low pH and high HCO3- levels. However, the patient also has respiratory alkalosis, as evidenced by the high PaCO2 levels. Therefore, the correct answer is D)Patients with metabolic acidosis with respiratory alkalosis.\n\n"}, {"question": "Thrombocythemia is characterized by", "correct_answer": "Neutrophilia", "options": ["A)Platelets elevation", "B)Low platelets", "C)Neutrophilia", "D)Monocytosis"], "prompt": "\n\nQ:Thrombocythemia is characterized byA)Platelets elevation B)Low platelets C)Neutrophilia D)Monocytosis\n\nA:", "output1": "\n<bot>: Thrombocythemia is a condition characterized by an increase in the number of platelets in the blood.\n\n", "output2": "\n<bot>: Thrombocythemia is characterized by a low platelet count, which is the opposite of thrombocytosis.\n\n", "output3": "\n<bot>: Thrombocythemia is characterized by an increase in neutrophils, not platelets.\n\n", "output4": "\n<bot>: Thrombocythemia is characterized by an increase in monocytes, which are a type of white blood cell.\n\n"}, {"question": "In eukaryotes, the RNA polymerase that transcribes the transference RNA genes is:", "correct_answer": "II.", "options": ["A)II.", "B)III.", "C)I.", "D)IV."], "prompt": "\n\nQ:In eukaryotes, the RNA polymerase that transcribes the transference RNA genes is:A)II. B)III. C)I. D)IV.\n\nA:", "output1": "\n<bot>: Because the RNA polymerase that transcribes the transfer RNA genes in eukaryotes is RNA polymerase II.\n\n", "output2": "\n<bot>: Because the RNA polymerase that transcribes the transfer RNA genes in eukaryotes is RNA polymerase III.\n\n", "output3": "\n<bot>: Because in eukaryotes, RNA polymerase I is responsible for transcribing the transfer RNA genes.\n\n", "output4": "\n<bot>: Because the RNA polymerase that transcribes the transfer RNA genes in eukaryotes is RNA polymerase IV.\n\n"}, {"question": "A 78-year-old woman presents a 2-year history of episodic amnesia that has been associated in recent months with difficulty recognizing familiar faces, apraxia of dress, anomie, and temporary disorientation. The family confirms a clear functional deterioration in instrumental activities of daily life with respect to its previous level. The patient shows a very evident anosognosia. General analytical studies, thyroid hormones and vitamin B12 are normal. Which of the following clinical findings did you NOT expect to find in this situation?", "correct_answer": "ApoE 3/4 heterozygous genotype.", "options": ["A)REM sleep behavior disorder.", "B)Medial temporal cortical atrophy in cerebral magnetic resonance.", "C)ApoE 3/4 heterozygous genotype.", "D)Neuritic plaques and neurofibrillary tangles in the hippocampus, temporal cortex and Meynert's nucleus as findings of pathological anatomy."], "prompt": "\n\nQ:A 78-year-old woman presents a 2-year history of episodic amnesia that has been associated in recent months with difficulty recognizing familiar faces, apraxia of dress, anomie, and temporary disorientation. The family confirms a clear functional deterioration in instrumental activities of daily life with respect to its previous level. The patient shows a very evident anosognosia. General analytical studies, thyroid hormones and vitamin B12 are normal. Which of the following clinical findings did you NOT expect to find in this situation?A)REM sleep behavior disorder. B)Medial temporal cortical atrophy in cerebral magnetic resonance. C)ApoE 3/4 heterozygous genotype. D)Neuritic plaques and neurofibrillary tangles in the hippocampus, temporal cortex and Meynert's nucleus as findings of pathological anatomy.\n\nA:", "output1": "\n<bot> B: Because REM sleep behavior disorder is characterized by dream-enactment behavior, which is not a common finding in dementia.\n\n", "output2": "\n<bot>: Medial temporal cortical atrophy in cerebral magnetic resonance is not expected to be found in a patient with episodic amnesia, apraxia of dress, anomie, and temporary disorientation, as these are not typical findings in this condition. The other options, such as REM sleep behavior disorder, apoE 3/4 heterozygous genotype, and neuritic plaques and neurofibrillary tangles in the hippocampus, temporal cortex and Meynert's nucleus, are more likely to be found in patients with Alzheimer's disease or other neurodegenerative disorders.\n\n", "output3": "\n<bot> A: Because the clinical findings described, such as episodic amnesia, apraxia of dress, anomie, and temporary disorientation, are not typical of Alzheimer's disease, which is the most common cause of dementia associated with the ApoE 3/4 heterozygous genotype. In addition, the patient's age and the presence of anosognosia are not typical of Alzheimer's disease.\n<human>", "output4": "\n<bot> A: Because the patient's symptoms are not consistent with an Alzheimer's disease diagnosis. Alzheimer's disease is characterized by the presence of neuritic plaques and neurofibrillary tangles in the hippocampus, temporal cortex, and other regions of the brain, as well as by the deposition of amyloid-\u03b2 peptides in the brain. However, in the case of the patient described, there is no mention of these findings in the clinical history or examination. Therefore, it is unlikely that the patient has Alzheimer's disease.\n\n"}, {"question": "IL- 1 activated by-", "correct_answer": "Capsase 8", "options": ["A)Capsase 3", "B)Capsase 1", "C)Capsase 5", "D)Capsase 8"], "prompt": "\n\nQ:IL- 1 activated by-A)Capsase 3 B)Capsase 1 C)Capsase 5 D)Capsase 8\n\nA:", "output1": "\n<bot>: Capsase 3 is a major activator of IL-1, and it is involved in the processing and activation of IL-1\u03b2.\n\n", "output2": "\n<bot> A: Capsase 1 is the primary activator of IL-1, and it is the most specific and potent activator of this cytokine.\n<human>", "output3": "\n<bot> A: Because Capsase 5 is a major activator of IL-1, and it is involved in the regulation of inflammation and immune response.\n\n", "output4": "\n<bot>: Capsase 8 is the primary activator of IL-1, and it is a cysteine protease that is involved in the activation of the cytokine. The other options, Capsase 3, Capsase 1, and Capsase 5, are also involved in the inflammasome pathway, but they are not the primary activators of IL-1.\n\n"}, {"question": "Parathormone stimulates the:", "correct_answer": "Renal phosphate reabsorption.", "options": ["A)Formation of 24,25 dihydroxycholecalciferol.", "B)Bone resorption by osteoclasts.", "C)Osteoprotegerin secretion by osteoblasts.", "D)Renal phosphate reabsorption."], "prompt": "\n\nQ:Parathormone stimulates the:A)Formation of 24,25 dihydroxycholecalciferol. B)Bone resorption by osteoclasts. C)Osteoprotegerin secretion by osteoblasts. D)Renal phosphate reabsorption.\n\nA:", "output1": "\n<bot> A: Parathyroid hormone (PTH) stimulates the formation of 24,25 dihydroxycholecalciferol (24,25D) in the kidneys. 24,25D is a precursor to 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), which is a potent regulator of calcium homeostasis.\n\n", "output2": "\n<bot> A: Parathormone (PTH) stimulates the activity of osteoclasts, leading to bone resorption.\n\n", "output3": "\n\n", "output4": "\n<bot> A: Parathyroid hormone (PTH) stimulates the renal tubular cells to increase phosphate reabsorption, which leads to an increase in serum phosphate levels.\n\n"}, {"question": "A 19-year-old woman is brought to the emergency department by ambulance after experiencing a first-time seizure. She as preparing for an exam at her college\u2019s library, in her normal state of health and collapsed. When she regained consciousness she was surrounded by students and staff. The emergency personnel assessed her condition and brought her in. Past medical history is significant for major depressive disorder. Her primary care physician prescribed a medication for her depression, but she has not taken it for several days because she was concerned about weight gain. Family medical history is insignificant for neurological disorders. Instead, for the past 10 days, she has been taking her roommate\u2019s antidepressant medication instead. Today her blood pressure is 100/80 mm Hg, pulse 102/min, respirations 12/min and he BMI is 15 kg/m2. Physical examination reveals pale and dry mucosa and conjunctiva, and lanugo on her arms and legs. What medication is the patient most likely taking?", "correct_answer": "Selegiline", "options": ["A)Gabapentin", "B)Bupropion", "C)Selegiline", "D)Amitriptyline"], "prompt": "\n\nQ:A 19-year-old woman is brought to the emergency department by ambulance after experiencing a first-time seizure. She as preparing for an exam at her college\u2019s library, in her normal state of health and collapsed. When she regained consciousness she was surrounded by students and staff. The emergency personnel assessed her condition and brought her in. Past medical history is significant for major depressive disorder. Her primary care physician prescribed a medication for her depression, but she has not taken it for several days because she was concerned about weight gain. Family medical history is insignificant for neurological disorders. Instead, for the past 10 days, she has been taking her roommate\u2019s antidepressant medication instead. Today her blood pressure is 100/80 mm Hg, pulse 102/min, respirations 12/min and he BMI is 15 kg/m2. Physical examination reveals pale and dry mucosa and conjunctiva, and lanugo on her arms and legs. What medication is the patient most likely taking?A)Gabapentin B)Bupropion C)Selegiline D)Amitriptyline\n\nA:", "output1": "\n<bot>: Gabapentin is a medication that is commonly used to treat seizures, and it is also known to cause weight gain, which is not a side effect of the other medications listed. Additionally, the patient's history of taking her roommate's antidepressant medication instead of her own prescribed medication, suggests that she may be taking something else that is not prescribed for her.\n\n", "output2": "\n<bot>: Bupropion is a medication that is commonly used to treat depression, and it is also known to cause weight loss. The patient's history of taking her roommate's antidepressant medication, along with her recent weight loss, suggests that she is likely taking Bupropion. Additionally, the patient's physical examination findings of pale and dry mucosa and conjunctiva, and lanugo on her arms and legs, are consistent with Bupropion use.\n\n", "output3": "\n<bot>: Selegiline is a medication that is commonly used to treat depression, and it is known to cause dry mouth, pale skin, and weight loss as side effects. The patient's symptoms of pale and dry mucosa and conjunctiva, and lanugo on her arms and legs, are consistent with these side effects. Additionally, the fact that she has been taking her roommate's antidepressant medication instead of her own prescribed medication, and the fact that she has a history of depression, suggest that she is likely taking Selegiline.\n\n", "output4": "\n<bot>: Amitriptyline is an antidepressant that is commonly prescribed for major depressive disorder, and it is known to cause weight gain. The patient's history of taking her roommate's antidepressant medication instead of her own prescribed medication, and her concern about weight gain, suggests that she is likely taking Amitriptyline. Additionally, the patient's physical examination findings of pale and dry mucosa and conjunctiva, and lanugo on her arms and legs, are consistent with the side effects of Amitriptyline.\n\n"}, {"question": "Which of the following is not a Lewy body dementia (dementia with Lewy bodies, DLB) are the main symptoms?", "correct_answer": "Good times and bad cognitive functions", "options": ["A)Visual hallucinations", "B)Good times and bad cognitive functions", "C)Chorea", "D)Parkinson's Symptoms"], "prompt": "\n\nQ:Which of the following is not a Lewy body dementia (dementia with Lewy bodies, DLB) are the main symptoms?A)Visual hallucinations B)Good times and bad cognitive functions C)Chorea D)Parkinson's Symptoms\n\nA:", "output1": "\n<bot>: Because dementia with Lewy bodies (DLB) is characterized by the presence of Lewy bodies in the brain, which are abnormal protein deposits that disrupt brain cell function. The main symptoms of DLB include cognitive impairment, such as memory loss and confusion, as well as changes in behavior and mood. Visual hallucinations are not a main symptom of DLB, although they can occur in some cases.\n\n", "output2": "\n<bot>: Because dementia with Lewy bodies (DLB) is characterized by a fluctuating course, with periods of good cognitive function and periods of decline. Therefore, good times and bad cognitive functions are not specific to DLB. The other options, visual hallucinations, chorea, and Parkinson's symptoms, are more common in DLB.\n\n", "output3": "\n<bot>: Chorea is not a symptom of Lewy body dementia. The main symptoms of Lewy body dementia are visual hallucinations, fluctuations in cognitive function, and parkinsonism.\n\n", "output4": "\n<bot>: Because Parkinson's symptoms are not a main symptom of dementia with Lewy bodies (DLB).\n<human>"}]